AstraZeneca: If requested, we will fully cooperate with Chinese law enforcement investigations and our business will continue
孤独雁1
发表于 10 小时前
1108
0
0
AstraZeneca once again responds to the investigation of its executives in China.
On November 5th local time, AstraZeneca's global website released a statement regarding stock price fluctuations, stating that according to policy, the company does not comment on speculative media reports, including those related to ongoing investigations in China. AstraZeneca emphasizes that if requested, it will fully cooperate with Chinese law enforcement agencies. The company will continue to provide drugs to Chinese patients and its business will continue.
On October 30th, the official websites of AstraZeneca Global and China announced that Wang Lei, AstraZeneca Global Executive Vice President, International Business Chairman, and China President, is cooperating with the investigation in China. AstraZeneca China is operating normally under the leadership of the current General Manager. If requested, AstraZeneca will fully cooperate with the investigation.
On November 4th, a reporter from The Paper noticed that the National Enterprise Credit Information Publicity System showed that the person in charge of AstraZeneca Pharmaceutical Co., Ltd. (legal representative, person in charge, chief representative, partnership affairs executor, etc.) had changed from Wang Lei to MAQDOSI EWA, with the change date being October 11, 2024.
On the same day, there were also changes in the market entity type and investors of AstraZeneca Pharmaceuticals Limited. The type of market entity has been changed from a limited liability company (Sino foreign cooperation) to a limited liability company (sole proprietorship of foreign legal persons). The change of investors (including the amount, method, date, and name of the investor) will be changed from Wuxi Xinfa Group Co., Ltd., Jiangsu Wuxi Pharmaceutical Co., Ltd., and AstraZeneca Continent B.V. to AstraZeneca Continent B.V.
As of the close on November 5th, AstraZeneca's US stock fell 7.22% and the UK stock fell 8.4%.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
-
【英偉達の需要が高すぎる?SKハイニックス:黄仁勲がHBM 4チップの6カ月前納入を要求!】SKハイニックスの崔泰源(チェ・テウォン)会長は月曜日、インビダーの黄仁勲(ファン・インフン)CEOが同社の次世代高帯域 ...
- 琳271
- 前天 17:54
- 支持
- 反对
- 回复
- 收藏
-
ファイザーが前立腺がんを治療する革新薬テゼナ& ;reg;(TALZENNA®,一般名:トルエンスルホン酸タラゾールパーリカプセル)は2024年10月29日に国家薬品監督管理局(NMPA)の承認を得て、HRR遺伝子突然変異 ...
- 什么大师特
- 昨天 17:41
- 支持
- 反对
- 回复
- 收藏
-
南方財経は11月5日、中央テレビのニュースによると、現地時間11月5日、米ボーイング社のストライキ労働者が59%の投票結果で新たな賃金協定を受け入れ、7週間にわたるストライキを終えた。ストライキ労働者は11月12 ...
- Dubssgshbsbdhd
- 昨天 16:27
- 支持
- 反对
- 回复
- 收藏
-
【マスクはテスラが携帯電話を作ることに応えた:作れるが作らないアップルとグーグルが悪さをしない限り】現地時間11月5日、有名ポッドキャストのジョローガン氏のインタビューに応じ、「携帯電話を作るのは私たち ...
- 波大老师
- 昨天 14:41
- 支持
- 反对
- 回复
- 收藏